Showing 241 - 260 results of 5,404 for search '"Thyroid cancer"', query time: 0.25s Refine Results
  1. 241
  2. 242
  3. 243
  4. 244
  5. 245
  6. 246

    Differentiated Thyroid Cancer: A Health Economic Review by Klaas Van Den Heede, Neil S. Tolley, Aimee N. Di Marco, Fausto F. Palazzo

    Published 2021-05-01
    “…The incidence of differentiated thyroid cancer (DTC) is rising, mainly because of an increased detection of asymptomatic thyroid nodularity revealed by the liberal use of thyroid ultrasound. …”
    Get full text
    Article
  7. 247

    Uptodate view on diagnostics and treatment of medullary thyroid cancer by D O Gazizova, D G Beltsevich

    Published 2013-09-01
    Subjects: “…medullary thyroid cancer…”
    Get full text
    Article
  8. 248

    EPIDEMIOLOGICAL CHARACTERISTICS OF THYROID CANCER IN THE DEVELOPED INDUSTRIAL REGION by R. M. Idiatullin, S. N. Styazhkina

    Published 2020-10-01
    “…The purpose of the study was to assess thyroid cancer epidemiology in the Udmurt Republic during 2008–18 and to estimate thyroid cancer raetes until 2023.Material and Methods. …”
    Get full text
    Article
  9. 249

    Radiation-Induced Thyroid Cancers: Overview of Molecular Signatures by Keiji Suzuki, Vladimir Saenko, Shunichi Yamashita, Norisato Mitsutake

    Published 2019-09-01
    “…Enormous amounts of childhood thyroid cancers, mostly childhood papillary thyroid carcinomas (PTCs), after the Chernobyl nuclear power plant accident have revealed a mutual relationship between the radiation exposure and thyroid cancer development. …”
    Get full text
    Article
  10. 250

    Salutary Response to Targeted Therapy in Anaplastic Thyroid Cancer by Sasan Fazeli MD, Edina Paal MD, Jessica H. Maxwell MD, Kenneth D. Burman MD, Eric S. Nylen MD, Shikha G. Khosla MD, MHA

    Published 2019-11-01
    “…Context . Anaplastic thyroid cancer (ATC) is an aggressive tumor with a median survival of 3 to 9 months, a 1-year survival of less than 10% and without definitive therapies. …”
    Get full text
    Article
  11. 251

    National Epidemiologic Survey of Thyroid cancer (NEST) in Korea by Chang-Mo Oh, Hyun-Joo Kong, Eunyang Kim, Hyejin Kim, Kyu-Won Jung, Sohee Park, Young-Joo Won

    Published 2018-10-01
    “…The Korea Central Cancer Registry conducted the National Epidemiologic Survey of Thyroid cancer (NEST) to investigate changes in the epidemiological and clinical characteristics of thyroid cancer patients between 1999 and 2008. …”
    Get full text
    Article
  12. 252
  13. 253
  14. 254

    Mutation Profile of Well-Differentiated Thyroid Cancer in Asians by Young Shin Song, Jung Ah Lim, Young Joo Park

    Published 2015-09-01
    “…Among the mutations commonly seen in thyroid cancers, the vast majority are associated with the mitogen-activated protein kinase pathway. …”
    Get full text
    Article
  15. 255

    Current capabilities of thyroid cancer diagnosis (literature review) by E. E. Bober, I, G, Frolova, E. L. Choinzonov, S. A. Velichko, N. Yu. Bystrova, M. R. Mukhamedov

    Published 2016-02-01
    “…The review deals with the problem of comprehensive diagnostic capabilities for thyroid cancer. In spite of the multiple studies, the question on the role of magnetic-resonance imaging in diagnostic algorithms for thyroid cancer remains disputable…”
    Get full text
    Article
  16. 256
  17. 257

    Protein molecular modeling of genetic markers for thyroid cancer by Luis Jesuino O. Andrade, Gabriela C. M. Oliveira, Alcina Maria V. Bittencourt, Paulo Roberto S. Melo

    “…ABSTRACT Introduction: The advances in thyroid molecular biology studies provide not only insight into thyroid diseases but accurate diagnosis of thyroid cancer. Objective: Design a tutorial on protein molecular modeling of genetic markers for thyroid cancer. …”
    Get full text
    Article
  18. 258
  19. 259
  20. 260

    Selective use of vandetanib in the treatment of thyroid cancer by Fallahi P, Di Bari F, Ferrari SM, Spisni R, Materazzi G, Miccoli P, Benvenga S, Antonelli A

    Published 2015-07-01
    “…Keywords: vandetanib, medullary thyroid cancer, papillary thyroid cancer, tyrosine kinase inhibitors, adverse events…”
    Get full text
    Article